

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.74727618 |
| 2 | complement activation, alternative pathway (GO:0006957) | 7.19072022 |
| 3 | drug catabolic process (GO:0042737) | 7.06892573 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 6.82297366 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 6.80981142 |
| 6 | * ethanol oxidation (GO:0006069) | 6.77065006 |
| 7 | regulation of protein activation cascade (GO:2000257) | 6.36566452 |
| 8 | regulation of complement activation (GO:0030449) | 6.14471255 |
| 9 | regulation of fibrinolysis (GO:0051917) | 6.12414534 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 6.07262602 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.89907960 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 5.89907960 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.65321901 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 5.43929803 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.43929803 |
| 16 | urea metabolic process (GO:0019627) | 5.40650378 |
| 17 | * ethanol metabolic process (GO:0006067) | 5.27845512 |
| 18 | drug metabolic process (GO:0017144) | 5.12759777 |
| 19 | protein carboxylation (GO:0018214) | 5.11421400 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.11421400 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 5.09874048 |
| 22 | fibrinolysis (GO:0042730) | 5.05175068 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.00919120 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.81818671 |
| 25 | cellular glucuronidation (GO:0052695) | 4.69817371 |
| 26 | triglyceride catabolic process (GO:0019433) | 4.65719679 |
| 27 | urea cycle (GO:0000050) | 4.58095836 |
| 28 | protein activation cascade (GO:0072376) | 4.52802072 |
| 29 | bile acid biosynthetic process (GO:0006699) | 4.50454485 |
| 30 | complement activation (GO:0006956) | 4.45836798 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.44430511 |
| 32 | glucuronate metabolic process (GO:0019585) | 4.41836565 |
| 33 | uronic acid metabolic process (GO:0006063) | 4.41836565 |
| 34 | negative regulation of protein activation cascade (GO:2000258) | 4.40095095 |
| 35 | regulation of plasminogen activation (GO:0010755) | 4.39237731 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.37774809 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.37774809 |
| 38 | bile acid metabolic process (GO:0008206) | 4.34366119 |
| 39 | complement activation, classical pathway (GO:0006958) | 4.31448518 |
| 40 | neutral lipid catabolic process (GO:0046461) | 4.30644412 |
| 41 | acylglycerol catabolic process (GO:0046464) | 4.30644412 |
| 42 | oxidative demethylation (GO:0070989) | 4.27839929 |
| 43 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.26611017 |
| 44 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.26611017 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.13418922 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.06988033 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.06988033 |
| 48 | negative regulation of complement activation (GO:0045916) | 3.98767430 |
| 49 | low-density lipoprotein particle clearance (GO:0034383) | 3.97787564 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 3.91617700 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 3.87821008 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 3.87680312 |
| 53 | negative regulation of sterol transport (GO:0032372) | 3.87680312 |
| 54 | phenylpropanoid metabolic process (GO:0009698) | 3.85253227 |
| 55 | primary alcohol catabolic process (GO:0034310) | 3.84513689 |
| 56 | acute-phase response (GO:0006953) | 3.81009986 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.80424304 |
| 58 | regulation of humoral immune response (GO:0002920) | 3.75825308 |
| 59 | negative regulation of coagulation (GO:0050819) | 3.73782058 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.73239417 |
| 61 | S-adenosylmethionine metabolic process (GO:0046500) | 3.64952311 |
| 62 | negative regulation of wound healing (GO:0061045) | 3.62191852 |
| 63 | response to mercury ion (GO:0046689) | 3.60370863 |
| 64 | regulation of sequestering of triglyceride (GO:0010889) | 3.59810600 |
| 65 | daunorubicin metabolic process (GO:0044597) | 3.55960998 |
| 66 | polyketide metabolic process (GO:0030638) | 3.55960998 |
| 67 | doxorubicin metabolic process (GO:0044598) | 3.55960998 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 3.48949121 |
| 69 | positive regulation of hemostasis (GO:1900048) | 3.48949121 |
| 70 | opsonization (GO:0008228) | 3.48845420 |
| 71 | * primary alcohol metabolic process (GO:0034308) | 3.47062395 |
| 72 | glycine metabolic process (GO:0006544) | 3.45057500 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 3.40975687 |
| 74 | macromolecular complex remodeling (GO:0034367) | 3.40975687 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.40975687 |
| 76 | positive regulation of lipid catabolic process (GO:0050996) | 3.40792736 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.39120946 |
| 78 | phospholipid homeostasis (GO:0055091) | 3.37731715 |
| 79 | negative regulation of lipase activity (GO:0060192) | 3.37041136 |
| 80 | oxaloacetate metabolic process (GO:0006107) | 3.34889600 |
| 81 | hormone catabolic process (GO:0042447) | 3.33167490 |
| 82 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.28785038 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.25845012 |
| 84 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.22326212 |
| 85 | positive regulation of coagulation (GO:0050820) | 3.19881600 |
| 86 | alkaloid metabolic process (GO:0009820) | 3.19609865 |
| 87 | fatty acid homeostasis (GO:0055089) | 3.17305056 |
| 88 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.16616032 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.15222385 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.13357580 |
| 91 | phospholipid efflux (GO:0033700) | 3.10968306 |
| 92 | cytolysis (GO:0019835) | 3.09100640 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 3.08651579 |
| 94 | arginine metabolic process (GO:0006525) | 3.03568661 |
| 95 | glycerolipid catabolic process (GO:0046503) | 3.02385988 |
| 96 | NADH metabolic process (GO:0006734) | 3.02358392 |
| 97 | regulation of cholesterol transport (GO:0032374) | 3.02192676 |
| 98 | regulation of sterol transport (GO:0032371) | 3.02192676 |
| 99 | diacylglycerol metabolic process (GO:0046339) | 3.00642215 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 2.98315876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.34218742 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.33461395 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.99636750 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.38270085 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.34952707 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.17900822 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.13538877 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.08909494 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.67673540 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57216792 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51080776 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35791410 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09153950 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.78732397 |
| 15 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67405740 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66327860 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60048081 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59195810 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58952162 |
| 20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57838905 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53626278 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53320303 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49107699 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46535925 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35950658 |
| 26 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.28095439 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27946284 |
| 28 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27675955 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26489356 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26100797 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23555838 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21006727 |
| 33 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21006727 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18190404 |
| 35 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.12178077 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10843044 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06518938 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06518938 |
| 39 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05321784 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04626836 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99526221 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99050268 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98549627 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97947101 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95717400 |
| 46 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95434521 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95241487 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94596090 |
| 49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93902089 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93760059 |
| 51 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.93166854 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91577372 |
| 53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91037653 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90315682 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89117505 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88236243 |
| 57 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87340965 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87196542 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86322166 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85498057 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84540286 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81463990 |
| 63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81209364 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80223586 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.79644017 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77777804 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76576560 |
| 68 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.76496362 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75197357 |
| 70 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.74676243 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.74676243 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74104009 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73930243 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.73928985 |
| 75 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73559027 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72972344 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72439252 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.71508188 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.71362513 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.70573429 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69830098 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68438772 |
| 83 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.67226530 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.65884355 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.65841479 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63267782 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62837815 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62246627 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.61898444 |
| 90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.61796473 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.61698722 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.61305715 |
| 93 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.60816870 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.60712812 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60615570 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.59667188 |
| 97 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.59415145 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.59137342 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59032087 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.58418814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.00104124 |
| 2 | MP0005670_abnormal_white_adipose | 4.51976229 |
| 3 | MP0005365_abnormal_bile_salt | 4.38028331 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.24794526 |
| 5 | MP0005360_urolithiasis | 4.19394404 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.74336261 |
| 7 | MP0003868_abnormal_feces_composition | 3.02112189 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.00982520 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.92710457 |
| 10 | MP0003195_calcinosis | 2.78889120 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.70764197 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.70629602 |
| 13 | MP0003252_abnormal_bile_duct | 2.66207586 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.58575367 |
| 15 | MP0004130_abnormal_muscle_cell | 2.45419874 |
| 16 | MP0002971_abnormal_brown_adipose | 2.45272646 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.41941539 |
| 18 | MP0005275_abnormal_skin_tensile | 2.33949196 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.18853318 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.07105248 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.03159974 |
| 22 | MP0001661_extended_life_span | 2.01204432 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.96569619 |
| 24 | MP0005375_adipose_tissue_phenotype | 1.84485192 |
| 25 | MP0005332_abnormal_amino_acid | 1.78197295 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.77614581 |
| 27 | MP0004272_abnormal_basement_membrane | 1.76584111 |
| 28 | MP0001958_emphysema | 1.71337360 |
| 29 | MP0009840_abnormal_foam_cell | 1.60523788 |
| 30 | MP0000609_abnormal_liver_physiology | 1.58632939 |
| 31 | MP0009115_abnormal_fat_cell | 1.51322034 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.48139403 |
| 33 | MP0005535_abnormal_body_temperature | 1.41014175 |
| 34 | MP0005334_abnormal_fat_pad | 1.39621211 |
| 35 | MP0006138_congestive_heart_failure | 1.37155349 |
| 36 | MP0003724_increased_susceptibility_to | 1.33853018 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.27633863 |
| 38 | MP0003690_abnormal_glial_cell | 1.27212326 |
| 39 | MP0003011_delayed_dark_adaptation | 1.26862364 |
| 40 | MP0003959_abnormal_lean_body | 1.25516280 |
| 41 | MP0003186_abnormal_redox_activity | 1.23361579 |
| 42 | MP0000751_myopathy | 1.21866263 |
| 43 | MP0001764_abnormal_homeostasis | 1.19159951 |
| 44 | MP0009697_abnormal_copulation | 1.18503746 |
| 45 | MP0002295_abnormal_pulmonary_circulatio | 1.14995727 |
| 46 | MP0002970_abnormal_white_adipose | 1.13925143 |
| 47 | MP0005164_abnormal_response_to | 1.10549479 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09454185 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.03993924 |
| 50 | MP0003828_pulmonary_edema | 1.02644633 |
| 51 | MP0005595_abnormal_vascular_smooth | 1.01219996 |
| 52 | MP0000249_abnormal_blood_vessel | 0.99281362 |
| 53 | MP0003279_aneurysm | 0.98392154 |
| 54 | MP0009643_abnormal_urine_homeostasis | 0.98257971 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 0.97100281 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.95884542 |
| 57 | MP0005023_abnormal_wound_healing | 0.95552268 |
| 58 | MP0005448_abnormal_energy_balance | 0.95200660 |
| 59 | MP0002108_abnormal_muscle_morphology | 0.93931972 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 0.91850124 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 0.84970124 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.83871394 |
| 63 | MP0004883_abnormal_blood_vessel | 0.82789900 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.80576209 |
| 65 | MP0005647_abnormal_sex_gland | 0.80367843 |
| 66 | MP0000343_altered_response_to | 0.78252491 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.77629239 |
| 68 | MP0009763_increased_sensitivity_to | 0.76587834 |
| 69 | MP0000598_abnormal_liver_morphology | 0.76530237 |
| 70 | MP0005385_cardiovascular_system_phenoty | 0.76209581 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 0.76209581 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.75550933 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.74781659 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.73858825 |
| 75 | MP0002933_joint_inflammation | 0.73621611 |
| 76 | MP0002133_abnormal_respiratory_system | 0.73418391 |
| 77 | MP0005388_respiratory_system_phenotype | 0.73418391 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.69559802 |
| 79 | MP0000604_amyloidosis | 0.65196862 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.64755659 |
| 81 | MP0002132_abnormal_respiratory_system | 0.63457695 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.61493804 |
| 83 | MP0003879_abnormal_hair_cell | 0.60187796 |
| 84 | MP0002128_abnormal_blood_circulation | 0.60034187 |
| 85 | MP0001851_eye_inflammation | 0.58606244 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.58381974 |
| 87 | MP0001915_intracranial_hemorrhage | 0.57208323 |
| 88 | MP0009764_decreased_sensitivity_to | 0.57080365 |
| 89 | MP0005452_abnormal_adipose_tissue | 0.56154163 |
| 90 | MP0003075_altered_response_to | 0.54081665 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.52706259 |
| 92 | MP0002060_abnormal_skin_morphology | 0.51850159 |
| 93 | MP0003091_abnormal_cell_migration | 0.50021235 |
| 94 | MP0008469_abnormal_protein_level | 0.49703041 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.49681143 |
| 96 | MP0009053_abnormal_anal_canal | 0.49584200 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.48749632 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.48139652 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.48108102 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.47767837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.73953902 |
| 2 | Abnormality of complement system (HP:0005339) | 8.21841101 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.19445200 |
| 4 | Deep venous thrombosis (HP:0002625) | 7.19008754 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 6.79798711 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.35759226 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.26031238 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.46030077 |
| 9 | Joint hemorrhage (HP:0005261) | 5.23812995 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.10141299 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 5.03270352 |
| 12 | Glomerulonephritis (HP:0000099) | 5.02055212 |
| 13 | Xanthomatosis (HP:0000991) | 4.42440888 |
| 14 | Nephritis (HP:0000123) | 4.09168667 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.92987017 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.86813317 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62400071 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55129810 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.53931775 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.52073965 |
| 21 | Hemorrhage of the eye (HP:0011885) | 3.25593405 |
| 22 | Oligomenorrhea (HP:0000876) | 3.25551061 |
| 23 | Spontaneous abortion (HP:0005268) | 3.13655781 |
| 24 | Protrusio acetabuli (HP:0003179) | 3.12570780 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.06748200 |
| 26 | Fat malabsorption (HP:0002630) | 3.05297312 |
| 27 | Hypertriglyceridemia (HP:0002155) | 3.02719853 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02345790 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.95279519 |
| 30 | Epidermoid cyst (HP:0200040) | 2.93889424 |
| 31 | Hypercholesterolemia (HP:0003124) | 2.90388601 |
| 32 | Mitral stenosis (HP:0001718) | 2.89925645 |
| 33 | Myocardial infarction (HP:0001658) | 2.77695214 |
| 34 | Aortic aneurysm (HP:0004942) | 2.77011128 |
| 35 | Steatorrhea (HP:0002570) | 2.73267373 |
| 36 | Acanthosis nigricans (HP:0000956) | 2.71492804 |
| 37 | Skin nodule (HP:0200036) | 2.69866508 |
| 38 | Delayed CNS myelination (HP:0002188) | 2.63983950 |
| 39 | Rickets (HP:0002748) | 2.55152010 |
| 40 | Polycythemia (HP:0001901) | 2.43061363 |
| 41 | Hyperammonemia (HP:0001987) | 2.35798229 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.32617979 |
| 43 | Neonatal hypoglycemia (HP:0001998) | 2.25744439 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24836664 |
| 45 | Gingival bleeding (HP:0000225) | 2.22814489 |
| 46 | Cardiovascular calcification (HP:0011915) | 2.15559805 |
| 47 | Amyloidosis (HP:0011034) | 2.14267620 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.10161895 |
| 49 | Purpura (HP:0000979) | 2.09306982 |
| 50 | Vascular calcification (HP:0004934) | 2.09139067 |
| 51 | Vascular tortuosity (HP:0004948) | 2.07125554 |
| 52 | Atrioventricular block (HP:0001678) | 2.05266580 |
| 53 | Hyperglycinemia (HP:0002154) | 2.04283420 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95653500 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 1.95653500 |
| 56 | Thrombophlebitis (HP:0004418) | 1.94027807 |
| 57 | Striae distensae (HP:0001065) | 1.93911758 |
| 58 | Esophageal varix (HP:0002040) | 1.92437086 |
| 59 | Lymphangioma (HP:0100764) | 1.92395955 |
| 60 | Broad metatarsal (HP:0001783) | 1.91311776 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90168581 |
| 62 | Vertebral compression fractures (HP:0002953) | 1.90068961 |
| 63 | Back pain (HP:0003418) | 1.88489761 |
| 64 | Increased connective tissue (HP:0009025) | 1.87735520 |
| 65 | Pulmonary embolism (HP:0002204) | 1.83768407 |
| 66 | Increased mean platelet volume (HP:0011877) | 1.83497013 |
| 67 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82900335 |
| 68 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82874874 |
| 69 | Osteomalacia (HP:0002749) | 1.82620109 |
| 70 | Aortic dissection (HP:0002647) | 1.80827036 |
| 71 | Insulin resistance (HP:0000855) | 1.78223946 |
| 72 | Abnormality of vitamin metabolism (HP:0100508) | 1.77889660 |
| 73 | Pigmentary retinal degeneration (HP:0001146) | 1.77575724 |
| 74 | Wrist flexion contracture (HP:0001239) | 1.76968083 |
| 75 | Hyperglycinuria (HP:0003108) | 1.74401750 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 1.73988953 |
| 77 | Menorrhagia (HP:0000132) | 1.73431905 |
| 78 | Potter facies (HP:0002009) | 1.69761420 |
| 79 | Facial shape deformation (HP:0011334) | 1.69761420 |
| 80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66485482 |
| 81 | Abnormal delivery (HP:0001787) | 1.66370510 |
| 82 | Stroke (HP:0001297) | 1.65830319 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 1.61995091 |
| 84 | Hydroxyprolinuria (HP:0003080) | 1.61995091 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 1.61877904 |
| 86 | Hyperbilirubinemia (HP:0002904) | 1.61423908 |
| 87 | Abnormal platelet volume (HP:0011876) | 1.61016940 |
| 88 | Fair hair (HP:0002286) | 1.60251943 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 1.58785235 |
| 90 | Spontaneous hematomas (HP:0007420) | 1.58588260 |
| 91 | Cerebral aneurysm (HP:0004944) | 1.57923441 |
| 92 | Visceral angiomatosis (HP:0100761) | 1.57591365 |
| 93 | Arterial tortuosity (HP:0005116) | 1.57517696 |
| 94 | Muscle fiber splitting (HP:0003555) | 1.56787190 |
| 95 | Aneurysm (HP:0002617) | 1.56016638 |
| 96 | Neonatal onset (HP:0003623) | 1.55441739 |
| 97 | Cerebral palsy (HP:0100021) | 1.54618655 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.50229652 |
| 99 | Spinal rigidity (HP:0003306) | 1.48686480 |
| 100 | Premature rupture of membranes (HP:0001788) | 1.48134924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 3.50134409 |
| 2 | RIPK1 | 3.47970266 |
| 3 | TIE1 | 3.39462076 |
| 4 | ERN1 | 3.37349500 |
| 5 | TGFBR2 | 2.94923795 |
| 6 | TRIB3 | 2.88078450 |
| 7 | DDR2 | 2.57932139 |
| 8 | EPHA3 | 2.49119959 |
| 9 | PDGFRA | 2.41888866 |
| 10 | SIK1 | 2.27874092 |
| 11 | FGFR4 | 2.20016694 |
| 12 | PRKAA2 | 2.13433469 |
| 13 | EPHB2 | 2.11744417 |
| 14 | LATS1 | 2.02597495 |
| 15 | NEK9 | 1.89500210 |
| 16 | MAP3K6 | 1.77720885 |
| 17 | TYK2 | 1.57856065 |
| 18 | EPHB1 | 1.56326301 |
| 19 | ABL2 | 1.53991310 |
| 20 | NLK | 1.53873335 |
| 21 | GRK5 | 1.43770636 |
| 22 | LATS2 | 1.43220450 |
| 23 | PRPF4B | 1.39621055 |
| 24 | KIT | 1.37045551 |
| 25 | JAK1 | 1.33355881 |
| 26 | PRKACG | 1.17995905 |
| 27 | MAPKAPK3 | 1.17845576 |
| 28 | EEF2K | 1.17067306 |
| 29 | MAPK4 | 1.16555492 |
| 30 | PIK3CG | 1.15773099 |
| 31 | MAPK7 | 1.15753882 |
| 32 | MAPK12 | 1.14192290 |
| 33 | PDGFRB | 1.13636774 |
| 34 | FER | 1.13222870 |
| 35 | CDC42BPA | 1.12449519 |
| 36 | TRPM7 | 1.11359132 |
| 37 | PDPK1 | 1.09492978 |
| 38 | TESK1 | 1.07944526 |
| 39 | PIK3CA | 1.07749236 |
| 40 | FGFR3 | 1.07332695 |
| 41 | GRK1 | 1.05338849 |
| 42 | STK38L | 1.00703096 |
| 43 | PINK1 | 0.96809096 |
| 44 | MAP3K13 | 0.96543686 |
| 45 | AKT3 | 0.92324914 |
| 46 | KDR | 0.90456070 |
| 47 | JAK2 | 0.90362163 |
| 48 | CAMK1 | 0.88704721 |
| 49 | PAK2 | 0.87288432 |
| 50 | TTN | 0.86995611 |
| 51 | PRKAA1 | 0.85159655 |
| 52 | CDK6 | 0.84589230 |
| 53 | CAMKK2 | 0.83896382 |
| 54 | MAP3K7 | 0.82002884 |
| 55 | IGF1R | 0.80396571 |
| 56 | GSK3A | 0.78457235 |
| 57 | PRKG1 | 0.76022492 |
| 58 | RET | 0.75782781 |
| 59 | ADRBK1 | 0.73052508 |
| 60 | PRKD1 | 0.70919757 |
| 61 | CSK | 0.70581357 |
| 62 | TBK1 | 0.68894796 |
| 63 | MAP3K3 | 0.68601045 |
| 64 | MAPK11 | 0.60735682 |
| 65 | MAP2K4 | 0.60330354 |
| 66 | MAP3K1 | 0.59022832 |
| 67 | SGK2 | 0.58675978 |
| 68 | STK38 | 0.57720911 |
| 69 | MAP2K1 | 0.57205535 |
| 70 | ZAP70 | 0.56826476 |
| 71 | SGK494 | 0.56716381 |
| 72 | SGK223 | 0.56716381 |
| 73 | MTOR | 0.54847240 |
| 74 | SGK3 | 0.50974336 |
| 75 | DAPK2 | 0.50480255 |
| 76 | MET | 0.49193702 |
| 77 | OBSCN | 0.49168858 |
| 78 | RPS6KA2 | 0.49135003 |
| 79 | MARK2 | 0.47192021 |
| 80 | CAMK1D | 0.46811770 |
| 81 | MAPK15 | 0.46688633 |
| 82 | PTK2 | 0.46529684 |
| 83 | PKN2 | 0.46150779 |
| 84 | MOS | 0.46075141 |
| 85 | MAPK3 | 0.44586628 |
| 86 | PRKACA | 0.43961521 |
| 87 | NTRK1 | 0.43925447 |
| 88 | SRC | 0.42904024 |
| 89 | PDK1 | 0.39819285 |
| 90 | LMTK2 | 0.39488182 |
| 91 | KSR2 | 0.39461074 |
| 92 | JAK3 | 0.39083790 |
| 93 | MST1R | 0.38866422 |
| 94 | ARAF | 0.38747662 |
| 95 | PRKACB | 0.38668867 |
| 96 | DAPK3 | 0.38510322 |
| 97 | FGFR2 | 0.38281113 |
| 98 | DMPK | 0.38126564 |
| 99 | PTK6 | 0.37380328 |
| 100 | RPS6KA3 | 0.37149444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.01819263 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.77924052 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.49714686 |
| 4 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.28518570 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23595791 |
| 6 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.12570667 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10334792 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.98293502 |
| 9 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.70683935 |
| 10 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.62392753 |
| 11 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.61541482 |
| 12 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 2.41838945 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37502468 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.35690034 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.34322496 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33891203 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.33060817 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19465013 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19273930 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.14807958 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95993152 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90562902 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.69316613 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67570890 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66691889 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64073342 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50065929 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46049680 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42981962 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34513533 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32784111 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29300651 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26594766 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19784406 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.18015072 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14321812 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.11677470 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10528941 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09032311 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08559206 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07460969 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05458849 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01391655 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98595457 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95356507 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.94471254 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88416192 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85500675 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83518384 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77765511 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72631144 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68833509 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66822869 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65761201 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65151623 |
| 56 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64309250 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.60095875 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.55429549 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51697847 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49658691 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.49488417 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47399521 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46142943 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41172965 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39189408 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37037902 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29441229 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28701113 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26552009 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26070167 |
| 71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.24434904 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.22904913 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21692155 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.19638317 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17538098 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16377884 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.15685719 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14743471 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.13990862 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.12695538 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.12541434 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12363823 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12236369 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12035908 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11290871 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07793428 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.05793423 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.04798362 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0900407 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0868341 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0748131 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0647665 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0602778 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0551057 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0476231 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0441540 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0397266 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0363037 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0356353 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0168657 |

